SightfileU.S. market data from official filings
Companies › CLSDQ
CLEARSIDE BIOMEDICAL INC (CLSDQ)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001539029 · EDGAR filings · Updated 2026-01-07
CLEARSIDE BIOMEDICAL INC (CLSDQ) has reported institutional ownership of 0.5%, with 1 institutional managers holding positions valued at $7.87K per the latest 13F reporting period. SEC filings include an active bankruptcy or receivership filing (8-K Item 1.03).
Institutional ownership
0.5%
Institutional managers
1
Reported 13F value
$7.87K
Data flags
1 active
from SEC filings
Latest updates
- 2026-01-07 — 15-12G filed
- 2025-12-29 — Current report (8-K) filed
- 2025-12-16 — EFFECT filed
- 2025-12-16 — EFFECT filed
- 2025-12-15 — S-8 POS filed
- 2025-12-15 — S-8 POS filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, CLEARSIDE BIOMEDICAL INC has 1 institutional holders and institutional ownership of 0.5%.
Data flags from SEC filings
Active bankruptcy or receivership filing (8-K Item 1.03), most recently filed 2025-12-29 (recurring since 2025-11-25) — source filing. The authoritative details are those stated in the filing itself.
Related companies
IM CANNABIS CORP (IMCC) · AYR Wellness Inc. (AYRWF) · United Health Prods Inc COM (UEEC) · NUO THERAPEUTICS INC (AURX) · XORTX THERAPEUTICS INC (XRTX) · VIREO GROWTH INC (VREOF)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-01-07.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-01-07.